Search:

Pharmaceuticals Headlines from PR Newswire


< Go Back

Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule
Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal Spanish
OncoTherapy Network Highlights National Blood Cancer Awareness Month
David Dreyer Appointed to Diplomat Board of Directors
MinuteClinic Walk-in Medical Clinics Opening in Memphis
Lyophilization Market Worth $5,121.5 Million by 2019
CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation
New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy
Asthma Drug Market 2023 Forecasts: US, 5EU & Japan Industry Analysis
Lpath, Inc. Announces $12.5 Million Registered Direct Offering
BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference
ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results
Soligenix Awarded NIAID Contract Valued up to $24.7 Million for the Development of Heat Stable RiVax™ Vaccine
First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines
Transparency Life Sciences To Conduct Sarcoidosis Trial For Auven Therapeutics' Kiacta™ Using Crowdsourcing And Telemonitoring
CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference
Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes
PCI Announces Acquisition Of Biotec
Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer
Low T Center Endorses The Joint FDA Committee Meeting on Testosterone
Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
FDA Approves Trulicity™ (dulaglutide), Lilly's Once-Weekly Therapy for Adults with Type 2 Diabetes
Sugar Alcohols - Global Strategic Business Report 201
BioSpecifics Technologies Corp. Announces New MULTICORD and Retreatment Data for XIAFLEX® for Dupuytren's Contracture Presented at American Society for Surgery of the Hand Annual Meeting
Patient Recruitment in Asia Biotech and Pharma Companies
At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients
ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform
Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar English
Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD
The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead
$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan
SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer
Alexza Pharmaceuticals and Ferrer Provide Update on ADASUVE® European Commercial Activities
Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program
Europe's Biggest and Longest-Running Gathering of Life Sciences Logistics, Supply Chain & QA Professionals English
Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors
Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors
Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver Cancer
Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients
CYRAMZA™ In Combination With Paclitaxel Significantly Improves Overall Survival In Second-Line Gastric Cancer Patients
Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens
Bayer plans to focus entirely on Life Science businesses
Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development
RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference
Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting
Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs
Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy
VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity
Exporters to Russia Facing Increasing Payment Risk
Latest Data Shows OrbusNeich's COMBO™ Dual Therapy Stent has Excellent Healing Benefits

< Prev Next >
PR Newswire - United Business Media